NEW YORK (GenomeWeb) – Biocept reported after the close of the market on Thursday that its second quarter 2017 revenues climbed to $1.3 million, up 93 percent from $663,000 in Q2 2016 when including the conversion of accrual-based revenue recognition, and up 64 percent excluding the impact of the conversion.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.